Approval · Notice of Compliance 3764 · 2004
CYCLOMEN: Notice of Compliance 3764
Issued June 10, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3764
- Date
- June 10, 2004
- Company
- Sanofi-Synthelabo Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to product monograph - revised indication and safety information
- Therapeutic class
- Pituitary gonadotropin inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYCLOMEN | Not yet assigned | — |